Stage
No active trials
Next date
None yet
Trials
0 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Atopic Dermatitis (AD), Eczema, Eczema Atopic Dermatitis
- Main trialPhase 2
- “This is a Phase 2a efficacy and safety study of EVO301 for the treatment of adults with atopic dermatitis.”In the company’s words, NCT06723405 on ClinicalTrials.gov
Other drugs for Atopic Dermatitis (AD)
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Completed | 17 Nov 2025 | Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026